Diego Alejandro Dri

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Advance Care Planning

Top Venues

Drug delivery and translational research

Pharmaceuticals (Basel, Switzerland)

Health and technology

This page only lists publications with an associated author ORCID identifier.

Publications

Diego Alejandro Dri, Federica Rinaldi, Maria Carafa, Carlotta Marianecci
Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes. Drug delivery and translational research (2022)
Maurizio Massella, Diego Alejandro Dri, Donatella Gramaglia
Regulatory Considerations on the use of Machine Learning based tools in Clinical Trials. Health and technology 12 (6) (2022)
Diego Alejandro Dri, Elisa Gaucci, Ilaria Torrieri, Maria Carafa, Carlotta Marianecci, Donatella Gramaglia
Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office. Pharmaceutics 14 (7) (2022)
Diego Alejandro Dri, Giulia Praticò, Elisa Gaucci, Carlotta Marianecci, Donatella Gramaglia
Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Diego Alejandro Dri, Carlotta Marianecci, Maria Carafa, Elisa Gaucci, Donatella Gramaglia
Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical Trials. Pharmaceutics 13 (3) (2021)